Skip to Main Content
Back to News

Lobbying Update: $40,000 of HACKENSACK MERIDIAN HEALTH lobbying was just disclosed

None

$40,000 of HACKENSACK MERIDIAN HEALTH lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, surprise medical billing, and Food is Medicine/nutrition. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023. Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. Issues related to Food is Medicine/nutrition."

You can find more data on corporate lobbying on Quiver Quantitative.

MRBK Insider Trading Activity

MRBK insiders have traded $MRBK stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MRBK stock by insiders over the last 6 months:

  • ANTHONY MARK IMBESI purchased 1,000 shares.
  • CHRISTOPHER J. ANNAS (Chairman & CEO) purchased 2,000 shares.
  • DENISE LINDSAY (EVP, Chief Financial Officer) purchased 1,500 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MRBK Hedge Fund Activity

We have seen 18 institutional investors add shares of MRBK stock to their portfolio, and 12 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles